City of London Group places 1.84m shares
Investment company City of London Group has placed just under 1.84m new ordinary shares at 70p each - a premium to the net asset value - representing 10 per cent of the current shares in issue.
Investment company City of London Group has placed just under 1.84m new ordinary shares at 70p each - a premium to the net asset value - representing 10 per cent of the current shares in issue.
The placing raised just under £1.286m before costs, which will be used to develop the company's existing business platforms, for working capital and to invest in new opportunities as they arise.
Eric Anstee, Chief Executive, said: "City of London Group has a history of recognising areas which are poorly served by current forms of finance and in particular bank lending. Through our business platforms we have been facilitating lending into the SME sector and we are pioneers in the litigation funding sector.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"This successful placing of £1.3m of new equity will enable us to fund the continued growth of our platforms as well as invest in further exceptional management teams as and when the opportunity arises."
The share price fell 3.27% to 74p by 13:27.
NR
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge